To systematically appraise and synthesize the best available evidence on screening and management strategies for stigma among patients with colorectal cancer and stomas.
Key Findings:
A total of 17 publications were included, comprising clinical decisions, clinical practice guidelines, expert consensuses, evidence summaries, a systematic review, and randomized controlled trials.
Seven thematic domains were identified: team construction, stigma identification and assessment, educational guidance, stoma and appliance management, self-management, psychosocial support, and follow-up.
32 evidence-based recommendations were generated for screening and managing stigma.
Interpretation:
Limitations:
Current evidence regarding stigma screening and management remains fragmented and generalized.
Lack of systematic synthesis limits application in standardized clinical practice.
Conclusion:
The study offers an evidence-based framework for stigma management among patients with colorectal cancer and stomas.
The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production
